All lobbying filings

Ferring Pharmaceuticals, Inc.

Ferring Pharmaceuticals, Inc. filed a Q1 report for Ferring Pharmaceuticals, Inc. on April 18, 2025.

Lobbying for Ferring Pharmaceuticals, Inc.

As filed: FERRING PHARMACEUTICALS, INC. for FERRING PHARMACEUTICALS, INC.

All filings by Ferring Pharmaceuticals, Inc. · Everything Ferring Pharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Expenses

$160,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill).

Taxation/Internal Revenue Code

Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill).

Bills named in this filing 1

H.R. 1878
IVF Access and Affordability Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.